Value
8.2/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 6.3 |
| P/S | 9.0 |
| EV/EBITDA | 5.7 |
| Fwd P/E | 9.6 |
| PEG | 10.0 |
| Analyst target | 7.5 |
- ▸Forward P/E: 7.6x
- ▸PEG: 0.09
- ▸Attractively valued
ANIP · Why this verdict
Why ANI Pharmaceuticals (ANIP) is rated HOLD
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictHOLD
Overall score6.4/10
ConfidenceMEDIUM
MacroRISK_OFF
Per-dimension breakdown
Quality
7.2/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 6.1 |
| ROA | 3.3 |
| Gross margin | 8.2 |
| Op margin | 6.5 |
| Net margin | 5.0 |
| Current ratio | 9.9 |
| FCF quality | 10.0 |
| Moat | 6.9 |
| Piotroski F | 8.9 |
- ▸Excellent cash conversion: 152% FCF/NI
- ▸Strong Piotroski F-Score: 8/9
Growth
8.8/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 7.6 |
| EPS growth | 10.0 |
- ▸Strong growth: 20% YoY
Momentum
4.7/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 4.5 |
| MACD | 1.7 |
| OBV | 10.0 |
| MA position | 7.2 |
| Volume | 0.0 |
- ▸Volume accumulation (rising OBV)
- ▸Below 200-MA but MA still rising (+1.4%/30d) — pullback in uptrend, not confirmed weakness
Sentiment
6.3/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 9.0 |
| erm sentiment | 5.0 |
- ▸Analyst upside: 36%
Insider
3.4/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 3.0 |
| insider conviction | 2.0 |
| holder change | 5.1 |
- ▸Notable insider selling — $6,348,562 (0.344% of mkt cap)
Peer rank
5.0/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 5.8 |
| quality rank | 6.1 |
| growth rank | 8.1 |
- ▸Industry growth leader
Technical
4.4/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 4.0 |
| support resistance | 3.1 |
| 52w position | 6.2 |
Risk (lower is worse)
4.8/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 8.3 |
| days to cover | 0.2 |
| volatility | 4.8 |
| put call | 4.4 |
| implied vol | 2.8 |
| max pain risk | 3.0 |
| beta | 10.0 |
| debt equity | 4.8 |
- ▸Short squeeze setup: 19% short, quality 7.5
- ▸High IV: 63%
- ▸Above max pain $70
- ▸Concentration risks: 1 HIGH, 1 MED (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
7.5/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
- ▸Perfect beat streak: 4Q
How the verdict was assembled
Engine trigger
Maintain position. Not compelling to add more.
Engine technical detail
verdict_path:
L4:PATH_F_HOLDPassed (7)
- MOMENTUM:4.7>=4.5
- ASYMMETRY:2.1>=1.5
- INSIDER:OK
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:59d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- 8K_CRITICAL:4.01
Warning (1)
- MOMENTUM:4.7<5.5 (soft — BUY_NOW allowed but watch)
Reward-to-Risk
2.12
Upside
+18.6%
Downside
8.8%
Sizing output
AVOID
SetupRANGE_BOUND — RSI 53 mid-range, Bollinger mid-band
EdgeNO_EDGE — No clear edge identified
SuitabilityAGGRESSIVE — MCap $1.8B<$5B
Investment implication
None of the engine's positive-conviction paths (C-quality, D-momentum) triggered — the F-path HOLD reflects balanced signals. Strongest-cleared gate: MOMENTUM:4.7>=4.5. Top dim: Growth at 8.8; weakest: Insider at 3.4. No conviction either direction.
The strongest dimensions are Growth at 8.8, Value at 8.2, and Catalyst at 7.5; the weakest are Insider at 3.4, Technical at 4.4, and Momentum at 4.7. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of 2.12 and an engine sizing output of AVOID.